Website Management Support Services

Request for Information (RFI) Responses are due no later than 5:30 P.M. Eastern Time on Saturday, 07 December 2020 THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS (RFQ); IT IS STRICTLY A REQUEST FOR INFORMATION (RFI), AND A CAPABILITIES STATEMENT. NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT. 1.0 DISCLAIMER: In accordance with Federal Acquisition Regulation (FAR) 15.201 "Exchange with industry before receipt of proposals," this RFI is for information and planning purposes only at this time, and shall not be construed as a solicitation or as an obligation on the part of the Congressionally Directed Medical Research Programs (CDMRP), or collaborative Department of Defense (DoD) activities. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained. 2.0 BACKGROUD: The United States Army Medical Research Acquisition Activity (USAMRAA), in support of the Congressionally Directed Medical Research Programs (CDMRP) began managing the Breast Cancer Research Program (BCRP) in fiscal year 1992 (FY92). With a Congressional appropriation of $210M in FY93, the CG established a team of individuals to administer the targeted appropriations. Congressional appropriations of over $15.9B have been made in FY1992-2020 for research to include breast, prostate, ovarian, lung, pancreatic and kidney cancer, defense health, neurofibromatosis, tuberous sclerosis complex, autism, psychological health/traumatic brain injury, spinal cord injury research, gulf war illness, multiple sclerosis, peer reviewed cancer, peer reviewed orthopedic and other programs. Together, these programs now comprise the office of the CDMRP. The CDMRP is the USAMRDC subordinate organization responsible for planning, coordinating, integrating, programming, budgeting and executing these programs. 3.0 SUBJECT: Congressionally Directed Medical Research Programs (CDMRP) is conducting market research in order to provide website management support services. CDMRP wishes to obtain information from small business contractors that possess the capability to provide the support services and other tasks listed in Attachment 1. 4.0 RESPONSE INSTRUCTIONS: Respondents should address the following in their submission: 1. Name and Address of company. 2. Any small business designation as certified by the Small Business Administration. 3. A thorough description of experience in providing support services requirements of this nature. Include in the description prior experience assisting with resolving any and all security vulnerability related findings, particularly if related to a DoD or Army web support requirement. 5.0 SUBMISSION CONTACT INFORMATION: All information regarding Capabilities Statements or any other proprietary information relative to this RFI shall be submitted via email to deanna.s.moose.civ@mail.mil no later than 5:00 pm EST on 07 December 2020. Telephonic communication will not be considered as submission nor receive response. Responses shall be limited to five pages and submitted via e-mail only. The font shall be Times New Roman, size 12, single space. Electronic files shall not exceed 3 MB. All submissions become Government property and will not be returned. THIS IS NOT A SOLICITATION ANNOUNCEMENT OR AN RFP AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT.